107 related articles for article (PubMed ID: 9158703)
21. Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.
Xing Y; Ning Y; Ru LQ; Wang LD
World J Gastroenterol; 2003 Jul; 9(7):1601-3. PubMed ID: 12854173
[TBL] [Abstract][Full Text] [Related]
22. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
Cayrol C; Knibiehler M; Ducommun B
Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
[TBL] [Abstract][Full Text] [Related]
23. Expression of p21 and MDM-2 proteins on tumor cells in responding and non-responding patients with Hodgkin's disease.
Smolewski P; Niewiadomska H; Krykowski E; Robak T
Neoplasma; 1999; 46(4):212-8. PubMed ID: 10613600
[TBL] [Abstract][Full Text] [Related]
24. Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival.
Amini RM; Enblad G; Engström P; Christensson B; Glimelius B; Sundström C
Leuk Lymphoma; 2002 Jun; 43(6):1253-60. PubMed ID: 12152993
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
[TBL] [Abstract][Full Text] [Related]
26. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
[TBL] [Abstract][Full Text] [Related]
27. DNA content and expression of PCNA and p53 in Hodgkin's disease and Hodgkin's-like B-cell lymphoma.
Czader M; Porwit A; Ost A; Auer G
APMIS; 1994 Nov; 102(11):865-73. PubMed ID: 7833007
[TBL] [Abstract][Full Text] [Related]
28. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair.
Gramantieri L; Trerè D; Chieco P; Lacchini M; Giovannini C; Piscaglia F; Cavallari A; Bolondi L
J Hepatol; 2003 Dec; 39(6):997-1003. PubMed ID: 14642618
[TBL] [Abstract][Full Text] [Related]
29. Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkins disease.
Pinheiro GS; Silva MR; Rodrigues CA; Kerbauy J; de Oliveira JS
Sao Paulo Med J; 2007 Mar; 125(2):77-84. PubMed ID: 17625704
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
[TBL] [Abstract][Full Text] [Related]
31. Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction.
Morrissey JJ; Ishidoya S; McCracken R; Klahr S
Kidney Int Suppl; 1996 Dec; 57():S84-92. PubMed ID: 8941927
[TBL] [Abstract][Full Text] [Related]
32. Localization of proliferating cell nuclear antigen (PCNA/Cyclin) in workshop cases of Hodgkin's disease and non-Hodgkin's lymphoma.
Kamel OW; Warnke RA; Banks PM
Semin Diagn Pathol; 1992 Nov; 9(4):311-4. PubMed ID: 1362284
[TBL] [Abstract][Full Text] [Related]
33. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
34. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
Dang CX; Han Y; Qin ZY; Wang YJ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
[TBL] [Abstract][Full Text] [Related]
36. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease.
Elenitoba-Johnson KS; Medeiros LJ; Khorsand J; King TC
Am J Clin Pathol; 1996 Dec; 106(6):728-38. PubMed ID: 8980348
[TBL] [Abstract][Full Text] [Related]
37. [The significance of p21 expression in gastric cancer].
Aoyagi K; Koufuji K; Kodama I; Yano S; Ohta J; Takamiya H; Mizutani K; Murakami N; Takeda J; Shirouzu K; Nakashima A
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():285-91. PubMed ID: 9263517
[TBL] [Abstract][Full Text] [Related]
38. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
39. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
40. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
